Evolus

EOLS
7.4208.96% ( +0.610 )
Closed: Nov 11, 16:00:00 (EDT)

About

Evolus
Evolus
EOLS.US

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Profile

Company Name
Evolus, Inc.
Market
NasdaqGM
Founded
Industry
--
Fiscal Year End
December 31

Related Securities

Industry

Management